Matthew Splett

The college’s investigators earned $19.4 million in NIH awards in 2025, according to the Blue Ridge Institute for Medical Research.

The three-year professorship appointment acknowledges Duarte’s career achievements while recognizing his continued ascent as a leader in precision medicine research.

PARADIGM at UF invites applications for its postdoctoral fellowship program in genomic medicine.

Every student in Dr. Jatinder Lamba’s lab who submitted an abstract earned an ASH award.

The bi-monthly, open-access journal publishes a range of article types, including original research articles, minireviews and viewpoints that address all areas of pharmacology and experimental therapeutics.

Dr. Peloquin was promoted to distinguished professor, the highest faculty honor at UF.

By allowing chemotherapy regimens to be personalized, a genetic score holds promise for improving treatment results in patients with acute myeloid leukemia (AML) who have traditionally had poor outcomes, UF Health researchers have found.

Dr. Cavallari's appointment follows two years of service in an interim chair role, during which she gained valuable experience leading the department’s 23 full-time faculty members.

The UF Cardio-Oncology Symposium on April 3 provided an engaging forum to spark new research collaborations. The event showcased how innovations in precision medicine, early detection and multidisciplinary collaboration are directly enhancing patient care.

UF Health researchers have used a promising approach by integrating CRISPR/cas9-based drug screening with patients’ clinical outcome to identify genes and pathways that predict how patients will respond to the standard firstline chemotherapy treatment regimen used to treat patients with acute myeloid leukemia, or AML.